OLBA HEALTHCARE HOLDINGS, Inc.

2689.T
Medical Distribution
2026/08/12 Updated
Market Cap: $71.2M (¥11.3B)
Stock Price: $12.01 (¥1,912)
Exchange Rate: 1 USD = ¥159.24

Orba HealthCare Holdings, Inc. 2026 June Term Financial Summary

For the six months ended June 2026, consolidated net sales were 12,659,500,000 yen, operating income was 1,679,828 thousand yen, and net income attributable to owners of the parent was 1,112,433 thousand yen. Year-over-year, net sales increased by 3.2%, operating income decreased by 15.2%, and net income decreased by 22.2%. Announced the integration with D VX to take place on September 1, 2026. For the six months ending June 2027, the outlook is not yet determined. Dividend at year-end: 80 yen per share; dividend policy for the current term is undecided due to the integration. Segments are three: medical devices, SPD, and nursing care products. Equity ratio improved to 28.0%. Cash and cash equivalents at period-end: 2,590 million yen. The financial summary is unaudited.

Importance:
Page Updated: August 12, 2026
IR Disclosure Date: August 12, 2026

Key Figures

  • 126,595,620千円: Sales(2026年6月期)
  • 1,679,828千円: Operating income(前年同期比△15.2%減)
  • 1,112,433千円: Net income attributable to owners of the parent(前年同期比△22.2%減)

AI要約

Section heading

Overview of earnings: For the six months ended June 2026, consolidated net sales were 12,659,500 thousand yen (up 3.2% YoY), but operating income declined to 1,679,828 thousand yen (down 15.2% YoY) and net income attributable to owners of the parent was 1,112,433 thousand yen (down 22.2% YoY). While pursuing price negotiations and cost-control initiatives in the mid-term plan, increases in raw material and logistics costs, rising labor costs, and integration-related expenses weighed on results. The company announced a management integration with D VX scheduled for September 2026, and plans to transition to the new post-integration structure.

Section 2 heading

Outlook: For the next period, the group-wide earnings outlook after the D VX integration will be disclosed as soon as it is determined. Segments focus on three divisions: medical devices, SPD, and nursing care products, with efforts in logistics, IT investment, human resource development, and BCP strengthening. The dividend policy remains to keep the 80 yen per share in this term, but will be decided based on the integration situation.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Orba HealthCare Holdings, Inc.

Company overview · Stock price · Financial data · All IR

View company page →